The association of cfDNA levels with serological parameters in both diseases, e.g., anti-dsDNA in SLE (154, 160) and ACPA and RF in RA (148, 155, 162), suggest that cfDNA may reflect common processes involved in both diseases, including inflammation and cell death. This evidence concerns the gene PRTN3 and rheumatoid arthritis.